Opdivo for Esophageal Carcinoma User Reviews
- Joy...
- Taken for 6 months to 1 year
- November 9, 2022
"Stay away from this drug if you have esophageal cancer. It won’t work for you but will destroy any 'itis' you might be susceptible to. It destroyed my husband’s thyroid, and they could never get it back to normal with meds. After 9 infusions, by month 10 his esophageal cancer was back with a vengeance. Opdivo does no good for esophageal patients. Just makes things worse."
See also:
Reviews may be edited to correct grammar/spelling or remove inappropriate content. Reviews appearing to come from parties with a vested interest are not published. This information is not intended to endorse any medication and should not replace the expertise and judgment of healthcare professionals.
More about Opdivo (nivolumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (96)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
- Breastfeeding
- En español
"Don’t take this drug, it only causes harm. After 4 treatments, it fried my thyroid and my adrenal glands. I’ve gone through hell for months as they try to adjust my medication. I will have to deal with this for the rest of my life. Your own immune system destroys your organs quickly."